-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Downgrades Theravance Biopharma to Neutral

Benzinga·06/29/2026 15:31:39
Listen to the news
BTIG analyst Julian Harrison downgrades Theravance Biopharma (NASDAQ:TBPH) from Buy to Neutral.